While several of the molecules associated with regulatory DC function (IL-10, TGFβ, IDO, PGE2, and CD25) have been elucidated and observed in numerous cancer entities and chronic infections, the molecular mechanisms reprogramming DC to become DCreg are still poorly understood. The gene discussed is TGFB1; the disease is cancer.